Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award
Grant Opportunity Analysis
The National Institutes of Health is seeking applications for the Clinical and Translational Science Awards Program: Collaborative and Innovative Acceleration Award cooperative agreement. Funded projects will support the collaborative development of innovative approaches, technologies, or models designed to enhance research impact, advance translational science, and accelerate the delivery of clinical treatments. Eligibility is limited to recipients that have successfully competed for an award under the CTSA UM1 Notice of Funding Opportunity PAR-24-272 or its subsequent iterations, serving as either a prime recipient or a partnering institution. Applications will undergo standard NIH peer-review processes to evaluate scientific and technical merit. The estimated synopsis close date is February 16, 2027, and inquiries can be directed to the Division of Clinical Innovation, NCATS at ctsa_collaborativeinnovation@mail.nih.gov.
Eligible Applicants
Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations, as either a prime recipient or as a partnering institution.
Grant Documents
No documents available for this grant.